The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
TEPEZZA teprotumumab 500 mg injection powder vial (444610)
ARTG Name
TEPEZZA teprotumumab 500 mg injection powder vial
Product name
TEPEZZA teprotumumab 500 mg injection powder vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Sponsor
Ingredients
teprotumumab
Licence category
RE
Licence status
A
Summary